刊名:Journal of Cancer Research and Clinical Oncology
出版年:2017
出版时间:February 2017
年:2017
卷:143
期:2
页码:361-368
全文大小:
刊物类别:Medicine
刊物主题:Oncology; Cancer Research; Internal Medicine; Hematology;
出版者:Springer Berlin Heidelberg
ISSN:1432-1335
卷排序:143
文摘
BackgroundApatinib, a third-line or later treatment for advanced gastric cancer (aGC), was shown to improve overall survival and progression-free survival (PFS) compared with placebo in the phase III trial. Given the modest benefit with high costs, we further evaluated the cost-effectiveness of apatinib for patients with chemotherapy-refractory aGC.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.